Janna Kiselar
Foghorn Therapeutics (United States)
ORCID: 0000-0002-6240-7522Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 17 papers. Top paper: “Selective PP2A Enhancement through Biased Heterotrimer Stabilization”.
Wei Huang, Sudeh Izadmehr, Caitlin M. O’Connor, Danica Wiredja, Zhizhi Wang +14 more
Erik R. Farquhar, Sichun Yang, David T. Lodowski, Janna Kiselar, Mark R. Chance
Laura Smith, Jürgen Bosch, James M. Seckler, Diana L. Kunze, Janna Kiselar +12 more
Awuri Asuru, Janna Kiselar, M. George, Mark R. Chance, Michael L. Gross +1 more
Bryan L. Roth, Michael Kinter, Ryan T. Strachan, Belinda Willard, Douglas J. Sheffler +1 more
Ward G. Walkup, Kirsty M. Hooper, Taoyingnan Li, Chieko Kishi‐Itakura, Aylwin Ng +21 more
Santosh Renuse, Simion Kreimer, Robert N. O’Meally, Peter Natov, Anil K. Madugundu +6 more
Chae Kim, Tracy Haldiman, Miroslava Kacířová, Benlian Wang, Jen Bohon +4 more
Nanak S. Dhillon, Erik R. Farquhar, Benlian Wang, Xiaolin Li, Janna Kiselar +2 more
Nanak S. Dhillon, Erik R. Farquhar, Benlian Wang, Xiaolin Li, Janna Kiselar +2 more
Hongyun Li, Janna Kiselar, Stephen P. Fink, Sagar Regmi, Alexander Day +6 more
Kanchustambham Vijayalakshmi, Rohit Jain, Benlian Wang, Janna Kiselar, Mark R. Chance +1 more
Hideharu Hashimoto, Yixuan Xie, Francisca N. de Luna Vitorino, Josue Baeza, Tam T. T. N. Nguyen +5 more
Erik R. Farquhar, Nanak S. Dhillon, Nayeon Jeon, Mark R. Chance, Janna Kiselar +1 more
Erik R. Farquhar, Nanak S. Dhillon, Nayeon Jeon, Mark R. Chance, Janna Kiselar +1 more
Rohit Jain, Daniela Schlatzer, Filipa Blasco Tavares Pereira Lopes, Janna Kiselar, David T. Lodowski +3 more
Chae Kim, Tracy Haldiman, Mohammad Khursheed Siddiqi, Krystyna Surewicz, Kiley Urquhart +10 more